Stay updated on SL-401 in BPDCN or AML Clinical Trial
Sign up to get notified when there's something new on the SL-401 in BPDCN or AML Clinical Trial page.

Latest updates to the SL-401 in BPDCN or AML Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.6%
- Check15 days agoChange DetectedDifference0.5%
- Check22 days agoChange DetectedThe page has been updated to reflect a new version (v2.15.0) and includes the addition of the term 'Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)' and the study identifier 'STML-401-0114', while significant details about the study's design and objectives have been removed.SummaryDifference37%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.3%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check44 days agoChange DetectedDifference0.3%
Stay in the know with updates to SL-401 in BPDCN or AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SL-401 in BPDCN or AML Clinical Trial page.